SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 55.95-0.6%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (8821)7/14/2003 7:53:25 PM
From: Biomaven  Read Replies (1) of 52153
 
Miljenko,

The study you quoted was for "asymptomatic" HRPC - my guess is that they were simply not as sick as those in the SPPI trial - certainly the control group statistics support this.

Also, my impression is (and maybe Stefaan can confirm this) that the US uses hormonal treatment earlier and more aggressively than is the case in Europe. Perhaps that might also explain some difference - the one trial was European, the other US.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News